Stay updated with breaking news from Dev mantena. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biological E India s next Serum, Bharat Biotech of COVID-19 vaccine The acquisition of Akorn India helped Biological E create a potential overall manufacturing capacity of over 1 billion doses per annum. PB Jayakumar | June 2, 2021 | Updated 23:07 IST Providence will provide necessary technology transfer for Biological E to manufacture mRNA vaccines in India. The oldest Indian private vaccine maker, Hyderabad-based Biological E Limited, is emerging as a domestic powerhouse of COVID-19 vaccine manufacturing following its latest deal with Canada-based biotech company Providence Therapeutics. In addition to the Providence deal, Biological E currently has a couple of in-house COVID-19 vaccines under development and another major manufacturing contract agreement for Johnson & Johnson s single-dose COVID-19 vaccine. It was among the earliest Indian companies to tap potential COVID-19 vaccine opportunities. ....
India s Biological E. to start vaccine late-stage trials in April: Executive SECTIONS Last Updated: Dec 18, 2020, 05:54 PM IST Share Synopsis The privately held company said in November it had started early-stage and mid-stage human trials of its vaccine candidate, being developed in collaboration with Baylor College of Medicine in Houston and U.S.-based Dynavax Technologies Corp, and expects results by February. Agencies Representative Image BENGALURU: India s Biological E. Ltd plans to start large late-stage trials of its potential COVID-19 vaccine candidate in April next year, according to a top executive at the Hyderabad-based drugmaker. The privately held company said in November it had started early-stage and mid-stage human trials of its vaccine candidate, being developed in collaboration with Baylor College of Medicine in Houston and U.S.-based Dynavax Technologies Corp, and expects results by February. ....
India's Biological E. to start vaccine late-stage trials in April - executive reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.